MedPath

bene-Arzneimittel GmbH

bene-Arzneimittel GmbH logo
🇩🇪Germany
Ownership
Private
Established
1949-01-01
Employees
101
Market Cap
-
Website
http://www.bene-arzneimittel.de

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

2

EMA:1
CIMA_AEMPS:1

Drug Approvals

Elmiron

Authorization Status
Authorised
Approval Date
Jun 2, 2017
EMA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis

Phase 4
Completed
Conditions
Bronchitis, Chronic
Pulmonary Disease, Chronic Obstructive
Interventions
Other: Placebo
Drug: Tacholiquine
First Posted Date
2015-08-05
Last Posted Date
2015-08-05
Lead Sponsor
bene-Arzneimittel GmbH
Target Recruit Count
27
Registration Number
NCT02515799
Locations
🇩🇪

Medaimun GmbH, Frankfurt/M, Hessen, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.